史录文/管晓东团队在抗菌药物分级管理政策评价中取得研究进展

中国药学(英文版) ›› 2024, Vol. 33 ›› Issue (1): 74-76.

史录文/管晓东团队在抗菌药物分级管理政策评价中取得研究进展

北京大学药学院药事管理与临床药学系

北京大学药学院药事管理与临床药学系

收稿日期:2024-01-18 修回日期:2024-01-18 接受日期:2024-01-18 出版日期:2024-01-31 发布日期:2024-03-03

The team of Prof. Luwen Shi and Prof. Xiaodong Guan made research progress in different restriction level adjustments on antibiotic use in China

Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University Health Science Center

Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University Health Science Center

Received:2024-01-18 Revised:2024-01-18 Accepted:2024-01-18 Online:2024-01-31 Published:2024-03-03

摘要/Abstract

摘要：

2023年12月22日, 北京大学药学院药事管理与临床药学系史录文/管晓东团队在医学权威期刊International Journal of Antimicrobial Agents在线发表了题为“The changes of different restriction level adjustments on antibiotic use in China”研究成果。该文评估分析了2013-2019年间中国抗菌药物分级管理政策调整对抗菌药物临床使用的影响。

Supporting:

北京大学药学院药事管理与临床药学系. 史录文/管晓东团队在抗菌药物分级管理政策评价中取得研究进展[J]. 中国药学(英文版), 2024, 33(1): 74-76.

Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University Health Science Center. The team of Prof. Luwen Shi and Prof. Xiaodong Guan made research progress in different restriction level adjustments on antibiotic use in China[J]. Journal of Chinese Pharmaceutical Sciences, 2024, 33(1): 74-76.